Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Smolen, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 56 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Schett, G; Tohidast-Akrad, M; Steiner, G; Smolen, J
      The stressed synovium

      ARTHRITIS RESEARCH
    2. Schett, G; Firbas, U; Fureder, W; Hiesberger, H; Winkler, S; Wachauer, D; Koller, M; Kapiotis, S; Smolen, J
      Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anaemia of systemic lupus erythematosus

      RHEUMATOLOGY
    3. Wells, G; Anderson, J; Beaton, D; Bellamy, N; Boers, M; Bombardier, C; Breedveld, F; Carr, A; Cranney, A; Dougados, M; Felson, D; Kirwan, J; Schiff, M; Shea, B; Simon, L; Smolen, J; Strand, V; Tugwell, P; van Riel, P; Welch, VA
      Minimal clinically important difference module: Summary, recommendations, and research agenda

      JOURNAL OF RHEUMATOLOGY
    4. Park, JW; Smolen, J
      Monoclonal antibody therapy

      ADVANCES IN PROTEIN CHEMISTRY, VOL 56
    5. Lindsey, M; Wedin, K; Brown, MD; Keller, C; Evans, AJ; Smolen, J; Burns, AR; Rossen, RD; Michael, L; Entman, M
      Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischernia/reperfusion

      CIRCULATION
    6. Aringer, M; Steiner, G; Graninger, W; Smolen, J
      Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on theeditorial by Pisetsky

      ARTHRITIS AND RHEUMATISM
    7. Schett, G; Hayer, S; Tohidast-Akrad, M; Schmid, BJ; Lang, S; Turk, B; Kainberger, F; Haralambous, S; Kollias, G; Newby, AC; Xu, QB; Steiner, G; Smolen, J
      Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice

      ARTHRITIS AND RHEUMATISM
    8. Sperr, WR; Natter, S; Baghestanian, M; Smolen, J; Wolff, K; Binder, BR; Muller, MR; Lechner, K; Valenta, R; Valent, P
      Autoantibody reactivity in a case of Schnitzler's syndrome: Evidence for aTh1-like response and detection of IgG2 anti-Fc epsilon RIa antibodies

      INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    9. Strand, V; Gladman, D; Isenberg, D; Petri, M; Smolen, J; Tugwell, P
      Endpoints: consensus recommendations from OMERACT IV

      LUPUS
    10. Galeazzi, M; Sebastiani, GD; Tincani, A; Piette, JC; Allegri, F; Morozzi, G; Bellisai, F; Scorza, R; Ferrara, GB; Carcassi, C; Font, J; Passiu, G; Smolen, J; Papasteriades, C; Houssiau, F; Nebro, AF; Garrido, ED; Jedryka-Goral, A; Marcolongo, R
      HLA class II alleles associations of anticardiolipin and anti-beta(2)GPI antibodies in a large series of European patients with systemic lupus erythematosus

      LUPUS
    11. Czerny, C; Grampp, S; Henk, CB; Neuhold, A; Stiskal, M; Smolen, J
      Rheumatoid arthritis of the craniocervical region: assessment and characterization of inflammatory soft tissue proliferations with unenhanced and contrast-enhanced CT

      EUROPEAN RADIOLOGY
    12. Stacher, G; Merio, R; Budka, C; Schneider, C; Smolen, J; Tappeiner, G
      Cardiovascular autonomic function, autoantibodies, and esophageal motor activity in patients with systemic sclerosis and mixed connective tissue disease

      JOURNAL OF RHEUMATOLOGY
    13. Galeazzi, M; Annunziata, P; Sebastiani, GD; Bellisai, F; Campanella, V; Ferrara, GB; Font, J; Houssiau, F; Passiu, G; Garrido, ED; Fernandez-Nebro, A; Bracci, L; Scorza, R; Puddu, P; Jedryka-Goral, A; Smolen, J; Tincani, A; Carcassi, C; Morozzi, G; Marcolongo, R
      Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations

      JOURNAL OF RHEUMATOLOGY
    14. Schett, G; Steiner, CW; Winkler, S; Graninger, W; Smolen, J; Xu, Q; Steiner, G
      Fas-activation inhibits activation of heat shock factor (hsF)-1 and expression of heat shock protein (hsp) 70

      ACTA MEDICA AUSTRIACA
    15. Schett, G; Rubin, RL; Steiner, G; Hiesberger, H; Muller, S; Smolen, J
      The lupus erythematosus cell phenomenon - Comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera

      ARTHRITIS AND RHEUMATISM
    16. Brooks, P; Emery, P; Evans, JF; Fenner, H; Hawkey, CJ; Patrono, C; Smolen, J; Breeveld, F; Day, R; Dougados, M; Ehrich, EW; Gijon-Banos, J; Kvien, TK; Van Rijswijk, MH; Warner, T; Zeidler, H
      Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2

      RHEUMATOLOGY
    17. Schett, G; Steiner, CW; Groger, M; Winkler, S; Graninger, W; Smolen, J; Xu, QB; Steiner, G
      Activation of Fas inhibits heat-induced activation of HSF1 and up-regulation of hsp70

      FASEB JOURNAL
    18. Galeazzi, M; Morozzi, G; Sebastiani, GD; Bellisai, F; Marcolongo, R; Cervera, R; Garrido, ED; Nebro, AF; Houssiau, F; Goral, AJ; Mathieu, A; Papasteriades, C; Piette, JC; Scorza, R; Smolen, J
      Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies (vol 16, pg 541, 1998)

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    19. Galeazzi, M; Bellisai, F; Sebastiani, GD; Morozzi, G; Marcolongo, R; Cervera, R; Garrido, ED; Nebro, AF; Houssiau, F; Goral, AJ; Mathieu, A; Papasteriades, C; Piette, JC; Scorza, R; Smolen, J
      Association of 16/6 and SA1 anti-DNA idiotypes with antibodies and clinical manifestations in a large cohort of SLE patients (vol 16, pg 717, 1998)

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    20. Strand, V; Gladman, D; Isenberg, D; Petri, M; Smolen, J; Tugwell, P
      Outcome measures to be used in clinical trials in systemic lupus erythematosus

      JOURNAL OF RHEUMATOLOGY
    21. Sebastiani, GD; Galeazzi, M; Tincani, A; Piette, JC; Font, J; Allegri, F; Mathieu, A; Smolen, J; Garrido, ED; Fernandez-Nebro, A; Jedryka-Goral, A; Papasteriades, C; Morozzi, G; Bellisai, F; De Pita, O; Marcolongo, R
      Anticardiolipin and anti-beta(2)GPI antibodies in a large series of European patients with systemic lupus erythematosus - Prevalence and clinical associations

      SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
    22. Maini, R; St Clair, EW; Breedveld, F; Furst, D; Kalden, J; Weisman, M; Smolen, J; Emery, P; Harriman, G; Feldmann, M; Lipsky, P
      Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

      LANCET
    23. Emery, P; Smolen, J
      Issues in rheumatoid arthritis

      LANCET
    24. Koller, M; Aringer, M; Kiener, H; Erlacher, L; Machold, K; Eberl, G; Studnicka-Benke, A; Graninger, W; Smolen, J
      Expression of adhesion molecules on synovial fluid and peripheral blood monocytes in patients with inflammatory joint disease and osteoarthritis

      ANNALS OF THE RHEUMATIC DISEASES
    25. STEINER G; SKRINER K; MIHOLITS M; PLOWS D; KOLLIAS G; SMOLEN J
      AUTOIMMUNITY TO HNRNP-A2 (RA33) IN HUMAN AND MURINE RHEUMATOID-ARTHRITIS

      The FASEB journal
    26. GALEAZZI M; MOROZZI G; SEBASTIANI GD; BELLISAI E; MARCOLONGO R; CERVERA R; GARRIDO ED; FERNANDEZNEBRO A; HOUSSIAU E; JEDRYKAGORAL A; MATHIEU A; PAPASTERIADES C; PIETTE JC; SCORZA R; SMOLEN J
      ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN 566 EUROPEAN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - PREVALENCE, CLINICAL ASSOCIATIONS AND CORRELATION WITH OTHER AUTOANTIBODIES

      Clinical and experimental rheumatology
    27. STOHLAWETZ P; HAHN P; KOLLER M; HAUER J; RESCH H; SMOLEN J; PIETSCHMANN P
      IMMUNOPHENOTYPIC CHARACTERISTICS OF MONOCYTES IN ELDERLY SUBJECTS

      Scandinavian journal of immunology
    28. WIESINGER GF; QUITTAN M; ARINGER M; SEEBER A; VOLCPLATZER B; SMOLEN J; GRANINGER W
      IMPROVEMENT OF PHYSICAL-FITNESS AND MUSCLE STRENGTH IN POLYMYOSITIS DERMATOMYOSITIS PATIENTS BY A TRAINING-PROGRAM/

      British journal of rheumatology
    29. Wiesinger, GF; Quittan, M; Graninger, M; Seeber, A; Ebenbichler, G; Sturm, B; Kerschan, K; Smolen, J; Graninger, W
      Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients

      BRITISH JOURNAL OF RHEUMATOLOGY
    30. SCHETT G; REDLICH K; XU QB; BIZAN P; GROGER M; TOHIDASTAKRAD M; KIENER H; SMOLEN J; STEINER G
      ENHANCED EXPRESSION OF HEAT-SHOCK-PROTEIN-70 (HSP70) AND HEAT-SHOCK FACTOR-1 (HSF1) ACTIVATION IN RHEUMATOID-ARTHRITIS SYNOVIAL TISSUE - DIFFERENTIAL REGULATION OF HSP70 EXPRESSION AND HSF1 ACTIVATION IN SYNOVIAL FIBROBLASTS BY PROINFLAMMATORY CYTOKINES, SHEAR-STRESS, AND ANTIINFLAMMATORY DRUGS

      The Journal of clinical investigation
    31. ERLACHER L; GRANINGER W; LUYTEN F; SMOLEN J
      STIMULATORY EFFECTS OF CARTILAGE-DERIVED MORPHOGENETIC PROTEINS AND OSTEOGENIC PROTEIN-1 ON CHONDROGENIC AND OSTEOGENIC DIFFERENTIATION OF THE MOUSE TERATOCARCINOMA CELL-LINE ATDC5

      Arthritis and rheumatism
    32. GALEAZZI M; SEBASTIANI GD; ANNUNZIATA P; MATHIEU A; SCORZA R; PAPASTERIADES C; SMOLEN J; HOUSSIAU F; CERVERA R; CAMPANELLA V; MARCOLONGO R
      CLINICAL AND GENETIC ASSOCIATIONS OF ANTI-GM1 ANTIBODIES IN A LARGE SERIES OF EUROPEAN PATIENTS WITH SLE

      Arthritis and rheumatism
    33. STELNER G; SKRINER K; PLOWS D; KOLLIAS G; KLARESKOG L; SMOLEN J
      AUTOANTIBODY FORMATION IN TNF-ALPHA TRANSGENIC MICE - A LINK BETWEEN CYTOKINE OVEREXPRESSION AND AUTOIMMUNITY IN RHEUMATOID-ARTHRITIS

      Arthritis and rheumatism
    34. LIPSKY P; STCLAIR W; KAVANAUGH A; MCCUNE W; SMOLEN J; BREEDVELD F; FURST D; KALDEN J; WEISSMAN M; BRAAKMAN T; SCHAIBLE T; MAINI R
      LONG-TERM CONTROL OF SIGNS AND SYMPTOMS OF RHEUMATOID-ARTHRITIS WITH CHIMERIC MONOCLONAL ANTI-TNF-ALPHA ANTIBODY (INFLIXIMAB) IN PATIENTS WITH ACTIVE DISEASE ON METHOTREXATE

      Arthritis and rheumatism
    35. LU H; HUGHES BJ; SMOLEN J; BALLANTYNE CM; TANG L; BEAUDET AL; SMITH CW
      ROLE OF MAC-1 (CD11B CD18) IN NEUTROPHIL FUNCTIONS IN-VIVO/

      The FASEB journal
    36. MERIO R; BUDKA C; SCHNEIDER C; HOLZAPFEL A; SMOLEN J; STACHER G
      CARDIOVASCULAR AUTONOMIC AND ESOPHAGEAL MOTOR DYSFUNCTION IN PATIENTSWITH PROGRESSIVE SYSTEMIC-SCLEROSIS (PSS) AND UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE (UCTD) IN RELATION TO PRESENCE OF SCL-70 AND U1-SNRNP AUTOANTIBODIES

      Gastroenterology
    37. ZAZGORNIK J; PIZA H; KAISER W; BETTELHEIM P; STEINER G; SMOLEN J; BIESENBACH G; MASCHEK W
      AUTOIMMUNE REACTIONS IN PATIENTS WITH SILICONE BREAST IMPLANTS

      Wiener Klinische Wochenschrift
    38. VALENTA R; MAURER D; STEINER R; SEIBERLER S; SPERR WR; VALENT P; SPITZAUER S; KAPIOTIS S; SMOLEN J; STINGL G
      IMMUNOGLOBULIN-E RESPONSE TO HUMAN PROTEINS IN ATOPIC PATIENTS

      Journal of investigative dermatology
    39. HITZELHAMMER J; SMOLEN J
      REACTIVE ARTHRITIS

      Hautarzt
    40. ANTONI C; MANGER B; REICHSTETTER S; SMOLEN J; BREEDVELD F; MAINI R; BIJL H; DEWOODY K; KALDEN J; WASSMUTH R
      THE HLA DR LOW AND DR4 HIGH-RESOLUTION BACKGROUND OF 55 PATIENTS WITHRHEUMATOID-ARTHRITIS TREATED WITH CA2 ANTIBODY AGAINST TUMOR-NECROSIS-FACTOR IN A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

      Arthritis and rheumatism
    41. STISKAL MA; NEUHOLD A; SZOLAR DH; SAEED M; CZERNY C; LEEB B; SMOLEN J; CZEMBIREK H
      RHEUMATOID-ARTHRITIS OF THE CRANIOCERVICAL REGION BY MR-IMAGING - DETECTION AND CHARACTERIZATION

      American journal of roentgenology
    42. STEINER G; STUDNICKABENKE A; WITZMANN G; HOFLER E; SMOLEN J
      SOLUBLE RECEPTORS FOR TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-2 IN SERUM AND SYNOVIAL-FLUID OF PATIENTS WITH RHEUMATOID-ARTHRITIS, REACTIVE ARTHRITIS AND OSTEOARTHRITIS

      Journal of rheumatology
    43. ERLACHER L; WINTERSBERGER W; MENSCHIK M; BENKESTUDNICKA A; MACHOLD K; STANEK G; SOLTZSZOTS J; SMOLEN J; GRANINGER W
      REACTIVE ARTHRITIS - UROGENITAL SWAB CULTURE IS THE ONLY USEFUL DIAGNOSTIC METHOD FOR THE DETECTION OF THE ARTHRITOGENIC INFECTION IN EXTRA-ARTICULARLY ASYMPTOMATIC PATIENTS WITH UNDIFFERENTIATED OLIGOARTHRITIS

      British journal of rheumatology
    44. WYLIE G; APPELBOOM T; BOLTEN W; BREEDVELD FC; FEELY J; LEEMING MRG; LELOET X; MANTHORPE R; MARCOLONGO R; SMOLEN J
      COMPARATIVE-STUDY OF TENIDAP, A CYTOKINE-MODULATING ANTIRHEUMATIC DRUG, AND DICLOFENAC IN RHEUMATOID-ARTHRITIS - A 24-WEEK ANALYSIS OF A 1-YEAR CLINICAL-TRIAL

      British journal of rheumatology
    45. PASSWELL JH; SHOR R; SMOLEN J; JAFFE CL
      INFECTION OF HUMAN MONOCYTES BY LEISHMANIA RESULTS IN A DEFECTIVE OXIDATIVE BURST

      International journal of experimental pathology
    46. LAKITS A; HALLER J; STEINER E; STENZEL I; SCHNEIDER B; CZEMBIREK H; SMOLEN J
      RADIOGRAPHIC CHANGES IN THE OS CALCIS IN RHEUMATOID-ARTHRITIS

      RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren
    47. STEINER G; STUDNICKABENKE A; HOFLER E; SMOLEN J
      SERUM LEVELS OF TNF-ALPHA AND SOLUBLE TNF RECEPTORS CORRELATE WITH DISEASE-ACTIVITY IN SLE

      The FASEB journal
    48. SMOLEN J
      DCT-ART - THE CONCEPT - COMMENT

      Journal of rheumatology
    49. BAKSHI R; THUMB N; BROLL H; KLEIN G; MAYRHOFER F; RAINER F; SINGER F; SMOLEN J
      TREATMENT OF ACUTE LUMBOSACRAL BACK PAIN WITH DICLOFENAC RESINATE - RESULTS OF A DOUBLE-BLIND COMPARATIVE TRIAL VERSUS PIROXICAM

      Drug investigation
    50. NEUHOLD A; CZERNY C; STISKAL M; BOHM G; SMOLEN J
      RHEUMATOID-ARTHRITIS OF THE ATLANTOAXIAL JOINT - ASCERTAINMENT OF THEINFLAMMATORY CHANGES BY MEANS OF CT AND MRI WITH CONTRAST-MEDIUM

      Radiologe
    51. STONE AT; TORRENTS A; SMOLEN J; VASUDEVAN D; HADLEY J
      ADSORPTION OF ORGANIC-COMPOUNDS POSSESSING LIGAND DONOR GROUPS AT THEOXIDE WATER INTERFACE

      Environmental science & technology
    52. ZIMMERMANN C; PRUIJN G; SMOLEN J; VANVENROOJI W; STEINER G
      INVESTIGATIONS ON THE STRUCTURE OF RO SSA RIBONUCLEOPROTEINS

      Arthritis and rheumatism
    53. STUDNICKABENKE A; STEINER G; HOFLER E; SMOLEN J
      CYTOKINES IN SLE - LEVELS OF IL-6, IFN-GAMMA, TNF-ALPHA AND TNF RECEPTOR (TNF-R) FLUCTUATE IN THE COURSE OF DISEASE

      Arthritis and rheumatism
    54. STEINER G; SKRINER K; SOMMERGRUBER WH; SMOLEN J
      RA33 - THE A2-PROTEIN OF THE HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN - ELISA AND EPITOPE MAPPING

      Arthritis and rheumatism
    55. STEINER G; STUDNICKABENKE A; WITZMANN G; PARTSCH G; SMOLEN J
      SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR (TNF-R) - HIGH SERUM LEVELS INRHEUMATOID-ARTHRITIS BUT NOT IN REACTIVE ARTHRITIS AND OSTEOARTHRITIS

      Arthritis and rheumatism
    56. GRANINGER W; AROCKERMETTINGER E; KIENER H; BENKE A; SZOTSSOTZ J; KNOBLER R; SMOLEN J
      HIGH-INCIDENCE OF ASYMPTOMATIC UROGENITAL INFECTION IN PATIENTS WITH UVEITIS ANTERIOR

      Documenta ophthalmologica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 20:26:06